Abstract Describing the Phase 1 Clinical Trial Data for EXT608 is Selected for the plenary session at ASBMR

Founder Laura Hales, PhD presented the poster titled, “EXT608 for the Treatment of Hypoparathyroidism: Phase 1 Trial Design and Results ” at The American Society for Bone and Mineral Research Annual Meeting in Vancouver, CA.

Click here to view the abstract (purchase/membership required) ->